🔬 Technical comparison · NeoPeptidos

Peptide comparison

MOTS-c vs SS-31: two ways of acting on the mitochondrion

Both are grouped as “mitochondrial” peptides, but the label hides fundamental differences. MOTS-c is made by the mitochondrion itself and acts as a signal to the rest of the cell; SS-31 is a synthetic tetrapeptide that travels to the inner mitochondrial membrane to stabilise it.

Compare mechanism, class, receptors and evidence. All compounds are offered with ≥99% purity verified by HPLC and a batch COA.

Tabla comparativa

  MOTS-cSS-31 (elamipretide)
OriginEncoded in mitochondrial DNA (12S rRNA gene)Synthetic
Size16 amino acids4 amino acids (D-Arg-Dmt-Lys-Phe-NH₂)
Described targetAMPK pathway and cell metabolism; can move to the nucleusCardiolipin in the inner mitochondrial membrane
RoleSignal from the mitochondrion to the cellRespiratory chain stabiliser
Research focusGlucose metabolism, exercise, ageingMitochondrial diseases, cardiac and muscle function
Development stagePreclinicalEvaluated in clinical trials

Analysis: how they differ

MOTS-c belongs to the mitochondrial-derived peptides: it was discovered by analysing the mitochondrial genome itself. In cell and animal models it has been linked to AMPK activation, insulin sensitivity and the response to exercise, and it has been described as moving to the nucleus under stress to influence gene expression. All of its evidence is, for now, preclinical.

SS-31 is not a signal but a tool: its structure, with positive charges and alternating aromatic amino acids, lets it concentrate in the inner mitochondrial membrane and bind to cardiolipin, protecting the organisation of the respiratory chain. Of the two, it is the one that has progressed furthest in clinical development, with trials in rare mitochondrial diseases.

💡 Want the complete scientific foundations? See the Peptide guide or the Certification in Peptide Science.

Frequently asked questions

Do MOTS-c and SS-31 work the same way?

No. MOTS-c is a peptide made by the mitochondrion that acts as a metabolic signal (AMPK pathway); SS-31 is a synthetic peptide that binds to and stabilises cardiolipin in the inner mitochondrial membrane.

What is cardiolipin?

A phospholipid found almost only in the inner mitochondrial membrane, essential for the respiratory chain complexes to work efficiently. It is the described target of SS-31.

Which one has more clinical evidence?

SS-31 (elamipretide), which has been evaluated in clinical trials. The evidence for MOTS-c is preclinical.

Otras comparativas

Explore these compounds in the catalog

Purity ≥99% verificada por HPLC and batch COA.

View full catalog →
Educational content for scientific purposes. Preclinical and clinical evidence are distinguished; it does not constitute medical advice or a recommendation for use. NeoPeptidos products are sold labeled for scientific research.